Where was Steve jobs on the Conference Call? Hes never really on a conference call....but an analyst asked if there was anything wrong with Steve Jobs health and the CFO said Steve Jobs health is a private matter.
A private matter? He is the face of the company.....he is the Warren Buffet of Apple.
Apple stock is plunging afterhours to $148. I have in my technical chart from the weekend that there is support at $145......but given the plunge....I'm waiting this one out!
Day Trading Blog - This Stock Blog gives insight on daily stock market trading as well as stock trading analysis. We also list stocks to buy, top stocks, stock picks, and the best stocks to invest in 2020. If you are looking for a stock blog about hot stocks that are rising, you came to the right place. Right now my top stocks for 2020 are TSLA, BYND, GBTC, SHLL > HYLN
Pages
▼
Monday, July 21, 2008
7/21 Pre Market Stock Gainers, DNA, FNM, FRE, ABK
This morning the Pre Market Gainers in the Stock Market are going to be:
DNA
FRE
FNM
ABK
WM
BAC
DNA is getting a buyout offer, Bank of America reported better then expected earnings, Fannie Mae and Freddie Mac are going up in sympathy to B of A.
Other Pre Market News.... Carl Ichan has been accepted to the Yahoo( YHOO ) board.
DNA
FRE
FNM
ABK
WM
BAC
DNA is getting a buyout offer, Bank of America reported better then expected earnings, Fannie Mae and Freddie Mac are going up in sympathy to B of A.
Other Pre Market News.... Carl Ichan has been accepted to the Yahoo( YHOO ) board.
Roche buying DNA Genentech
Roche has offered to buy the rest of Genentech DNA for 43.7 Billion dollars. As you might know already, Roche already owns a 55.9 percent stake in DNA.
The Swiss drug maker Roche is offering $89 per share for the remaining DNA shares.
Genentech is trading above $96 in pre market so far this morning so it looks like their could be a taken over battle here. The market is pricing in a higher takeover price.
On another note, Merck MRK is postponing earnings until tonight at 4pm.
The Swiss drug maker Roche is offering $89 per share for the remaining DNA shares.
Genentech is trading above $96 in pre market so far this morning so it looks like their could be a taken over battle here. The market is pricing in a higher takeover price.
On another note, Merck MRK is postponing earnings until tonight at 4pm.